Rapid Respiratory Disease Test

Full molecular workflow consolidated into one small benchtop platform

Comprises sarbecovirus as a confirmatory target accurately diagnosing COVID-19

Powered by Randox Biochip Technology enabling multiple results from one patient sample

Target genes in line with WHO & CDC recommendations

Easy 4 step process from sample entry to results. No laboratory training required.

Clinical Significance

The Viral Respiratory Tract Infections (VRI) test offers a rapid and comprehensive solution, capable of detecting 10 different viral respiratory infections, including SARS-CoV-2, within a remarkably short timeframe of 2 hours and 30 minutes.

This extensive panel equips healthcare providers with the ability to swiftly identify potential co-infections, thereby enabling them to make more informed treatment decisions for patients grappling with respiratory illnesses. The expedited detection of multiple viruses not only aids in timely intervention but also holds the promise of reducing unnecessary antibiotic usage, consequently leading to improved patient outcomes and more effective management of respiratory conditions.

Features

Detection Method: Randox Biochip Technology (end-point PCR)

Vivalytic Workflow

Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.

To begin the test, the user scans or enters sample information. The cartridge code is then scanned into the embedded Vivalytic software. The user then adds sample into the dedicated cartridge slot, closes the lid and inserts the cartridge into the Vivalytic.